ZNF417 Activators
ZNF417 can engage in a variety of cellular signaling pathways to modulate the function of this protein. Forskolin is known for its ability to directly activate adenylyl cyclase, leading to an increased production of cyclic AMP (cAMP) within the cell. The rise in cAMP levels can activate protein kinase A (PKA), which in turn can phosphorylate numerous substrates including ZNF417, thereby influencing its activity. Similarly, Phorbol 12-myristate 13-acetate (PMA) functions by activating protein kinase C (PKC), a key player in several signal transduction pathways. The activation of PKC often results in the phosphorylation of proteins that can include ZNF417, altering its conformation and function. Ionomycin, as a calcium ionophore, raises intracellular calcium levels which can activate calcium-dependent protein kinases, potentially leading to the phosphorylation of ZNF417.
Insulin can engage the PI3K/Akt signaling pathway, with Akt kinase being capable of phosphorylating numerous proteins that may affect ZNF417's function. The Epidermal Growth Factor (EGF) and Basic Fibroblast Growth Factor (FGF-basic) both function through receptor tyrosine kinases, EGFR and FGFR respectively, initiating downstream MAPK/ERK signaling cascades that can lead to the phosphorylation of various transcription factors and may involve ZNF417. Bradykinin, through its B2 receptor, Histamine via the H1 receptor, Glutamate through its receptors, and Serotonin binding to 5-HT receptors, all can initiate cellular responses that result in the activation of PKC and MAPK pathways. These pathways can converge to phosphorylate ZNF417. Acetylcholine, through muscarinic receptors, and Anandamide, through cannabinoid receptors, engage in similar signaling mechanisms, activating intracellular pathways such as PLC and MAPK, which can lead to the activation of ZNF417 through phosphorylation events. These diverse chemical activators, through their respective signaling pathways, can collectively contribute to the regulation of ZNF417 activity within cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which is involved in several signal transduction pathways. PKC-mediated phosphorylation can lead to changes in protein conformation and function, potentially including the activation of ZNF417. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore which increases intracellular calcium levels. Elevated calcium can activate calcium-dependent protein kinases, which may phosphorylate and activate ZNF417 as part of downstream signaling. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt signaling pathway, which is known to regulate a wide range of cellular functions. Akt can phosphorylate substrates that may interact with or modify the activity of ZNF417, leading to its activation. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin activates the bradykinin B2 receptor which can lead to increased intracellular calcium and activation of PKC and MAPK pathways. These pathways may converge to phosphorylate and activate ZNF417. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine, through its H1 receptor, activates phospholipase C, which increases IP3 and DAG, leading to a rise in intracellular calcium and activation of PKC. Such signaling may contribute to the activation of ZNF417. | ||||||
L-Glutamic Acid | 56-86-0 | sc-394004 sc-394004A | 10 g 100 g | $297.00 $577.00 | ||
Glutamate acts on its receptors, leading to activation of intracellular signaling cascades such as CaMK and PKC, which could lead to activation of ZNF417 through subsequent phosphorylation events. | ||||||
3-(2-Aminoethyl)-1H-indol-5-ol | 50-67-9 | sc-298707 | 1 g | $530.00 | 3 | |
Serotonin binds to 5-HT receptors, leading to activation of various signal transduction pathways, including PKC and MAPK, which might result in the phosphorylation and activation of ZNF417. | ||||||